arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Tilray Brands, Inc.

TLRY
$4.58 ▲ +0.13 (+2.92%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
11 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
34
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

Tilray Brands, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $512.2M
Dividend Yield
Revenue Growth 11.5%
Op. Margin -6.9%
ROIC -5.0%
FCF / Share $-0.62
Trailing P/E
Price / Book 0.3x
FCF Yield
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$915.45M
↑ +11.5%
Net Income Profit after all expenses
$-121.40M
↑ +94.4%
Operating Margin Operating profit as % of sales
-6.9%
↑ +97.5% 17th
FCF / Share Free cash flow per share
$-0.62
↓ -481.9%
Long-Term Debt Long-term obligations
$185.70M
↓ -9.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
13
Returns
29
Financial Health
66
Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 39 quarters